Non-metastatic Prostate Cancer
11 clinical trials · Condition
◉ Watch Non-metastatic Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide (NCT04335682) | Alliance Foundation Trials, LLC. | 2021-08-17 |
| PROState Pathway Embedded Comparative Trial (NCT04400656) | Imperial College London | 2020-09-08 |
| Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer (NCT04049747) | Imperial College London | 2019-12-11 |
| Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer (NCT00239291) | AstraZeneca | 2003-01-01 |
| Casodex vs Placebo in Non-Metastatic Early Prostate Cancer (NCT00672282) | AstraZeneca | 1995-10-01 |
| (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer (NCT00673205) | AstraZeneca | 1995-09-01 |
| Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer (NCT00657904) | AstraZeneca | 1995-08-01 |
Track Non-metastatic Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.